Activatable fluorescent probes for real-time imaging-guided tumor therapy

QJ Duan, ZY Zhao, YJ Zhang, L Fu, YY Yuan… - Advanced Drug Delivery …, 2023 - Elsevier
Surgery and drug therapy are the two principal options for cancer treatment. However, their
clinical benefits are hindered by the difficulty of accurate location of the tumors and timely …

Inflammatory processes in cardiovascular disease: a route to targeted therapies

N Ruparelia, JT Chai, EA Fisher… - Nature reviews …, 2017 - nature.com
Inflammatory processes are firmly established as central to the development and
complications of cardiovascular diseases. Elevated levels of inflammatory markers have …

In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

A Refaat, ML Yap, G Pietersz, APG Walsh… - Journal of …, 2022 - Springer
Advances in diagnostic imaging have provided unprecedented opportunities to detect
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …

Endoscopic optical coherence tomography: technologies and clinical applications

MJ Gora, MJ Suter, GJ Tearney, X Li - Biomedical optics express, 2017 - opg.optica.org
In this paper, we review the current state of technology development and clinical
applications of endoscopic optical coherence tomography (OCT). Key design and …

[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment

X Zhang, F Centurion, A Misra, S Patel, Z Gu - Advanced drug delivery …, 2023 - Elsevier
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …

Coronary atherosclerotic vulnerable plaque: current perspectives

C Stefanadis, CK Antoniou, D Tsiachris… - Journal of the American …, 2017 - Am Heart Assoc
Atherosclerosis is the most common form of vascular disease and constitutes the major
cause of death, with 17.5 million related deaths annually (31% of global mortality). 1 …

Nanotechnology for cardiovascular diseases

Q Hu, Z Fang, J Ge, H Li - The Innovation, 2022 - cell.com
Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …

[HTML][HTML] Intracoronary optical coherence tomography: state of the art and future directions: State of the art in OCT

Z Ali, KK Galougahi, GS Mintz, A Maehara… - …, 2021 - ncbi.nlm.nih.gov
Optical coherence tomography (OCT) has been increasingly utilised to guide percutaneous
coronary intervention (PCI). Despite the diagnostic utility of OCT, facilitated by its high …

Myocardial infarction—From atherosclerosis to thrombosis: Uncovering new diagnostic and therapeutic approaches

J Palasubramaniam, X Wang… - … , thrombosis, and vascular …, 2019 - Am Heart Assoc
One of the earliest and best-recognized elements of atherosclerosis is its close relationship
with circulating LDL (low-density lipoprotein). There is convincing evidence that LDL …

Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis–novel insights and future directions in diagnosis and therapy

A Hartley, D Haskard, R Khamis - Trends in Cardiovascular Medicine, 2019 - Elsevier
We provide an up-to-date overview of current topics surrounding oxidized low-density
lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at …